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Abstract
Introduction: Inflammatory involvement of the anterior chest wall (ACW) affects the quality of life of patients with
spondyloarthritis (SpA), although involvement of the ACW is often neglected on clinical and imaging evaluation.
Whole-body (WB) MRI is an imaging method used to assess the ACW in addition to the sacroiliac joints and spine
without inconvenience for patients. Our goals in this study were to describe the distribution of ACW inflammation
by WB MRI in both early and established SpA and associations between clinical and imaging findings indicative of
inflammation.
Methods: The ACWs of 122 consecutive SpA patients (95 with ankylosing spondylitis (AS) and 27 with
nonradiographic SpA (nrSpA)) and 75 healthy controls were scanned by sagittal and coronal WB MRI. The MRI
scans were scored independently in random order by seven readers blinded to patient identifiers. Active and
structural inflammatory lesions of the ACW were recorded on a web-based data entry form. ACW pain by patient
self-report, ACW tenderness on physical examination according to the Maastricht Ankylosing Spondylitis Enthesitis
Score (MASES) and lesions detected by MRI were analyzed descriptively.  statistics served to assess the agreement
between clinical and imaging findings.
Results: ACW pain or tenderness was present in 26% of patients, with little difference between AS and nrSpA
patients. Bone marrow edema (BME), erosion and fat infiltration were recorded in 44.3%, 34.4% and 27.0% of SpA
patients and in 9.3%, 12.0% and 5.3% of controls, respectively. Lesions found by MRI occurred more frequently in
AS patients (BME, erosion and fat infiltration in 49.5%, 36.8% and 33.7%, respectively) than in nrSpA patients (25.9%,
25.9% and 3.7%, respectively). The joint most frequently affected by lesions found on MRI scans was the
manubriosternal joint. The  values between clinical assessments and MRI inflammation ranged from -0.10 to only
0.33 for both AS and nrSpA patients.
Conclusions: Among SpA patients, 26% had clinical involvement of the ACW. WB MRI signs of ACW inflammation
were found in a substantial proportion of patients with AS (49.5%) and nrSpA (25.9%). There was no association
between clinical assessments of ACW, including the MASES, and MRI features.
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Introduction
Inflammatory involvement of the anterior chest wall
(ACW) has substantial impact on the quality of life of
patients with spondyloarthritis (SpA) [1]. However,
ACW involvement is often neglected in clinical assess-
ment. Researchers in uncontrolled studies of ACW
inflammation who assessed the association between clin-
ical features and various abnormalities using different
imaging modalities have shown inconsistent results
regarding the frequency of ACW involvement and asso-
ciations with imaging findings [2-7]. This may partly
reflect the lack of a systematic methodology and inclu-
sion of patients at various stages of disease.
Conventional MRI limited to the ACW region is rarely
performed in routine clinical practice, even in the pre-
sence of ACW pain in SpA patients. Whole-body (WB)
MRI is a recently introduced imaging modality based on
multichannel technology, which offers an opportunity to
evaluate inflammation of the ACW (Figures 1 and 2) in
addition to the entire spine, the sacroiliac joints (SIJs)
and the shoulder and hip girdle in a single examination
that takes about 30 minutes [8-10]. Advantages of MRI
over radiography, computed tomography and scintigra-
phy for imaging the ACW are the concomitant assess-
ment of active and structural lesions, the precise
anatomical visualization of inflammatory lesions due to
superior spatial and contrast resolution, multiplanar
capability and the absence of radiation [11].
The objectives of this study were (1) to conduct a sys-
tematic and controlled evaluation of the frequency and
anatomical distribution of active and structural lesions
detected by MRI in the ACW of patients with ankylos-
ing spondylitis (AS) and nonradiographic axial SpA
(nrSpA) and (2) to assess the association between clini-
cal and imaging findings of ACW inflammation.
Materials and methods
Patients
In this cross-sectional study, we enrolled 95 patients
who met the modified New York classification criteria
for AS [12] and 27 patients with nrSpA who fulfilled the
Assessment of SpondyloArthritis International Society
(ASAS) classification criteria for axial SpA [13] and also
had inflammatory back pain according to the Calin cri-
teria [14]. The patients were consecutively recruited
from a university rheumatology outpatient clinic (Balgr-
ist University Hospital, Zürich, Switzerland). There were
no limitations on the age and disease duration in our
patient group representative of patients seen in routine
practice in a tertiary care center. Patients undergoing
ongoing therapy with and those who had been treated
previously with biological agents were excluded from
the study. A control group of 75 healthy volunteers was
recruited from the staff of the same university hospital
that enrolled the SpA patients. The control subjects
were selected on the basis of the absence of clinically
relevant back pain according to the Nordic question-
naire [15] and had no symptoms of SpA in their medical
history. All study subjects underwent a WB MRI exami-
nation, including imaging of the ACW in the coronal
and sagittal planes. Approval by the local Ethics Com-
mittee was obtained (Kantonale Ethikkommission Zür-
ich and Spezialisierte Unterkommission Orthopädie/
Bewegungsapparat, EK 37/2004), and all study subjects
gave their written informed consent.
Clinical assessment of anterior chest wall pain
Physician assessment
ACW tenderness according to the Maastricht Ankylos-
ing Spondylitis Enthesitis Score (MASES) [16] was
assessed in the 122 SpA patients. MASES is the only
one of six available enthesitis indices to include tender
points of the ACW [17]. Tenderness of the first and
seventh sternocostal joints on both sides was recorded
dichotomously as present or absent in a diagrammatic
ACW scheme. We standardized pressure intensity as
that level which elicited pallor of the distal nail bed
upon palpation with the patient in a supine position
during the examination. A positive physician assessment
was defined as tenderness in at least one of the four
MASES locations. The physician was not aware of the
patient’s self-assessment form at the time of the clinical
examination or of the WB MRI findings, both of which
were performed after the physician assessment.
Patient self-assessment
Patients recorded pain in the anterior rib cage on a form
representing a manikin. This form was filled in after the
clinical consultation if the WB MRI took place the same
day or the patient returned the form on the day the WB
MRI was scheduled. Patient self-assessment forms were
available for only 73 of the 122 SpA patients because
the manikin form was introduced two years after start
of the WB MRI program. A positive patient assessment
was defined as any indication of pain on the manikin
form in an area bordered cranially by the sternoclavicu-
lar joints (SClJs) and clavicles, caudally by the inferior
rib cage and laterally by the anterior axillary line. This
extended area for pain records was chosen because
referred pain to areas distant from inflamed sternal
joints has been well-described [18-20].
MRI protocol
WB MRI scans are composed of images of the upper
and the lower half of the trunk that are fused by dedi-
cated software. To blind the readers regarding inflam-
mation of the lower half of the spine and the SIJ, only
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Figure 1 Inflammatory lesions of the anterior chest wall displayed by whole-body MRI in an AS patient complaining about chest wall
pain. Bone marrow edema (arrows) in both parts of the manubriosternal joint on coronal and sagittal short τ inversion recovery (STIR)
sequences in a 46-year-old human leukocyte antigen B27 (HLA-B27)-positive male patient with ankylosing spondylitis and anterior chest wall
pain. He had a 6-year history of inflammatory back pain. The arrowheads point to the mammary veins.
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Figure 2 MRI inflammation of the anterior chest wall in an AS patient without clinical signs of chest wall involvement. Bone marrow
edema (dashed arrows) of the fourth and fifth right sternocostal joints on frontal and sagittal STIR sequences in a 26-year-old HLA-B27-positive
female patient with ankylosing spondylitis but no anterior chest wall pain. The patient reported a 2-year history of inflammatory back pain. Bone
marrow edema is also seen in the lower portion of the manubriosternal joint on the left side (arrow). The mammary veins are indicated by
arrowheads.
Weber et al. Arthritis Research & Therapy 2012, 14:R3
http://arthritis-research.com/content/14/1/R3
Page 4 of 11
the nonfused sagittal and coronal MRI scans of the
upper half of the trunk were used for this study. The
WB MRI studies were acquired using a MAGNETOM
Avanto 1.5 T MRI scanner (Siemens Medical Solutions,
Erlangen, Germany). The detailed WB MRI protocol has
been described previously [9,10]. Briefly, the following
parameters were used to obtain the sagittal images.
Turbo short τ inversion recovery (STIR) repetition time
(TR) was 6,270 ms, echo time (TE) 93 ms, inversion
time (TI) 130 ms, T1-weighted spin-echo (T1SE) MRI
sequences TR 401 ms and TE 11 ms. Two sequences
were used with a field of view (FOV) of 450 mm and an
imaging matrix of 780 × 448 mm (STIR) and 890 × 448
mm (T1SE), 3-mm section thickness and interslice gap
0.3 mm. For coronal sequences the parameters were
turbo STIR TR 9,860 ms, TE 99 ms, TI 130 ms. For
T1SE, the parameters were TR 571 ms and TE 12 ms.
The FOV was 450 × 450 mm for each sequence, ima-
ging matrix 660 × 384 pixels, slice thickness 5 mm and
interslice gap 1.0 mm.
Analysis of MR images (Figures 1 and 2)
STIR and T1SE sequences of sagittal and coronal MRI
scans of the ACW were scored independently by seven
readers from four institutions (five radiologists: AGJ,
AZ, JH, RGL and SD; and two rheumatologists: UW
and WPM) blinded to subject identifiers. The films were
evaluated in random order on electronic work stations
at the institution of each reader.
Definitions of lesions of the anterior chest wall detected by
MRI
We developed standardized definitions of active and
structural inflammatory lesions in the ACW detected by
MRI. These focused on bone marrow edema (BME)
seen on STIR images; joint erosion and marrow fat infil-
tration on T1SE images of the SClJ, manubriosternal
joint (MSJ) and sternocostal joint (SCoJ); synovitis of
the SClJ on STIR sequences; and fusion of the MSJ on
T1SE sequences. The primary reference for normal
bone marrow signal intensity was the center of the ster-
nal manubrium or body on the STIR sequence. In the
setting of diffuse sternal inflammation, the center of a
normal thoracic vertebra at the same craniocaudal level
constituted the reference normal signal.
BME was defined as bright subchondral bone marrow
signal on STIR images. Erosion was defined as a full-
thickness defect of articular cortical bone combined
with an altered bone marrow signal on T1SE images.
Fat infiltration was defined as focal bright subcortical
bone marrow signal on T1SE images. Synovitis of the
SClJ was recorded when fluid accumulation was present
in the joint cavity or extended at least 5 mm lateral to
the SClJ. Fusion of the MSJ was defined by bone
marrow signal on T1SE images extending partially or
completely across the joint space.
Reference magnetic resonance image set of the anterior
chest wall
A reference MR image set based on the definitions for
these five types of acute and structural inflammatory
lesions of the three joints of the ACW was developed by
consensus among the seven readers. The reference
image set also included normal ACW findings and ana-
tomical variants and served to calibrate the observers at
the time of reading the study MRI scans.
Standardized assessment of lesions of the anterior chest
wall detected by MRI and online data entry module
The MRI findings were entered into a customized web-
based module displaying a schematic of the three joints
of the ACW, which comprised the following eight loca-
tions: the clavicular and sternal portion of both SClJs,
the upper and lower parts of the MSJ and the right and
left SCoJs. BME, erosion and fat infiltration were
recorded dichotomously as being present or absent in
all eight locations. Synovitis and bone fusion were
recorded only for the SClJs and the MSJ, respectively.
Statistical analysis
Frequency of lesions found by MRI
The distribution of the five lesions detected by MRI in
patients and controls for the three joints and the entire
ACW (at least one of three joints affected) was analyzed
descriptively by defining “presence” as an observation
recorded concordantly by the majority (at least four of
seven) of raters. This approach of reporting the lesion
frequency according to the majority of the seven obser-
vers was regarded as an optimal balance between sensi-
tivity and specificity to avoid overinterpretation of
scattered lesions found by MRI as indicated by a single
observer or a minority of readers only.
Reliability of lesion detection by MRI
Interobserver agreement was analyzed by the median of
the pairwise estimated Cohen’s  values [21] for the 21
possible reader pairs, for all five lesion types and for the
three ACW joints, respectively. The interreader agree-
ment was defined as slight, fair, moderate, substantial
and almost perfect by values of the estimated Cohen’s 
< 0.2, 0.2 ≤  < 0.4, 0.4 ≤  < 0.6, 0.6 ≤  < 0.8 and 0.8
≤  < 1, respectively [22].
Agreement between patient and physician assessment, and
association between clinical and MRI findings of the
anterior chest wall
For those 73 SpA patients for whom both clinical
assessments were available, agreement between patient
and physician assessments was evaluated by computing
Cohen’s  value [21]. The agreement between clinical
findings (for both patient and for physician assessment)
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and lesions of the ACW detected by MRI was analyzed
by providing the median of Cohen’s  of all seven indi-
vidual readers. A positive patient assessment (n = 73) or
physician assessment (n = 122) has been defined above
(clinical assessment of ACW pain). Lesions found on
MRI (BME, erosion or fat infiltration) were regarded as
present if the abnormality was recorded in at least one
of eight ACW joint locations by each of the seven read-
ers. This approach to select only lesions observed on
MRI studies by all seven readers aimed at high specifi-
city for comparison with the two clinical assessment
methods where ACW pain was either present or absent.
The agreement was calculated for the SpA, AS and
nrSpA groups and for BME, erosion and fat infiltration
of the ACW, respectively. The same definitions to inter-
pret the  values regarding the degree of agreement
were applied as described above. It is possible for the 
value to be negative, indicating that there is less agree-
ment than would be expected by chance between two
assessment methods.
Results
Characteristics of the patient and control group
Demographic and clinical data of the patients and con-
trols are shown in Table 1. The median age of the AS
group was 35.7 years, of the nrSpA patients 27 years
and of the controls 30.3 years, respectively. 87.1% of the
AS patients and 88.9% of the nrSpA patients were
human leukocyte antigen B27-positive. The median
symptom duration in the AS group was 11 years com-
pared with 1.2 years in the nrSpA group.
Clinical evaluation of anterior chest wall inflammation by
patient and physician assessments
The frequency of ACW pain by patient assessment and
of ACW tenderness by physician assessment is displayed
in Table 2. In SpA patients, both clinical assessments
showed the same frequency of ACW involvement of
26% with little difference between the AS and the
nrSpA group despite the different median disease dura-
tions of 11.0 versus 1.2 years. The agreement between
patient and physician assessments was moderate with an
estimated Cohen’s  value of 0.50 (95% CI = 0.24 to
0.71).
Distribution of inflammatory anterior chest wall lesions
found by whole-body MRI
The frequency of inflammatory lesions of the entire
ACW in SpA patients scanned by MRI was 44.3% for
BME, 34.4% for erosions and 27.0% for fat infiltration,
respectively (Table 3). Any of these types of lesions
detected by MRI was observed more frequently than the
clinical involvement of the ACW in 26% of the SpA
patients. All lesion types were recorded more frequently
in AS patients than in nrSpA patients: BME in 49.5%
versus 25.9%, erosion in 36.8% versus 25.9% and fat
infiltration in 33.7% versus 3.7%, respectively. On a joint
level, the most frequently affected joint by all three
lesions was the MSJ (33.6% for BME, 30.3% for erosion
and 20.5% for fat infiltration in the SpA group), followed
by the SClJ (23.8%, 11.5% and 10.7%, respectively),
whereas the SCoJs were only rarely involved (6.6%, 0%
and 3.3%, respectively). Postinflammatory fusion of the
MSJ was detected in AS patients only (14.7%). Both
sides of the SClJ were equally affected by synovitis in
the SpA group (in six and in five patients on the right
and the left sides, respectively, and in five patients on
both sides).
The seven readers were in substantial agreement for
BME of the MSJ, with a median  of 0.65. Erosions and
fat infiltration of the MSJ also showed the highest relia-
bility (median  0.46 and 0.47, respectively) compared
with the other two ACW joints. The only lesion type
showing moderate agreement in the SClJ was BME ( =
Table 1 Characteristics of the study subjectsa
Variable SpA group
(n = 122)
AS group
(n = 95)
nrSpA group
(n = 27)
Control group
(n = 75)
Male:female ratio (% male) 90:32 (73.8) 73:22 (76.8) 17:10 (63.0) 42:33 (56.0)
Age, years 33.8 [17.3 to 71.6] 35.7 [17.3 to 71.6] 27.0 [18.8 to 44.8] 30.3 [17.7 to 63.8]
Symptom duration, years 7.0 [0.3 to 41.0] 11.0 [0.3 to 41.0] 1.2 [0.3 to 5.0] N/A
HLA-B27-positive, n (%)b 105/120 (87.5) 81/93 (87.1) 24/27 (88.9) N/A
BASDAI, NRS range 0 to 10 4.4 [0.4 to 9.0] 4.6 [0.4 to 9.0] 3.9 [0.8 to 6.3] N/A
BASFI, NRS range 0 to 10 2.9 [0 to 8.2] 3.2 [0 to 7.8] 2.1 [0 to 8.2] N/A
BASMI, NRS range 0 to 10 1.0 [0 to 8.0] 1.0 [0 to 8.0] 0 [0 to 4.0] N/A
CRP level, mg/L 5.0 [0 to 150.0] 5.0 [0 to 57.0] 3.0 [0 to 150.0] N/A
ESR (mm/hour) 12.5 [1.0 to 72.0] 14.0 [2.0 to 69.0] 8.5 [1.0 to 72.0] N/A
aAS = ankylosing spondylitis; BASDAI = Bath Ankylosing Spondylitis Disease Activity Index [23]; BASFI = Bath Ankylosing Spondylitis Functional Index [24]; BASMI
= Bath Ankylosing Spondylitis Metrology Index [25]; CRP = C-reactive protein, reference range ≤5 mg/L; ESR = erythrocyte sedimentation rate; HLA-B27 = human
leukocyte antigen B27; N/A = not applicable; NRS = numeric rating scale; nrSpA = nonradiographic axial spondyloarthritis; SpA = spondyloarthritis. bHLA-B27 was
not tested in two patients in the AS group. Values for the continuous demographic and clinical variables are medians [IQR] unless otherwise stated.
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0.49). The poor reliability of all lesion types in the SCoJ
computed by  statistics resulted from the low number
of scattered lesions recorded by the seven readers, as 
values depend on the prevalence of the finding under
observation [26,27]. The  values for the most experi-
enced of the 21 possible reader pairs and for the MSJ
were 0.78 for BME, 0.73 for erosion and 0.67 for fat
infiltration, respectively, indicating substantial agreement
for all three lesions.
In the control group, lesions seen on MRI that were
compatible with BME were observed in 9.3%, erosions
in 12.0% and fat infiltration in 5.3%, respectively. Nearly
all lesions reported in healthy controls were seen in the
MSJ (8.0% for BME, 9.3% for erosion and 4.0% for fat
infiltration), with few lesions in the SClJ (1.3%, 2.7% and
1.3%, respectively) and no inflammatory changes in the
SCoJ, respectively.
Association between clinical and MRI findings indicative
of anterior chest wall inflammation
There was a poor association between clinical and MRI
findings indicative of ACW inflammation by the med-
ian  value of all seven individual readers (Table 4).
For the SpA group, the agreement between ACW ten-
derness in at least one of four MASES locations (physi-
cian assessment) and BME recorded in at least one of
eight ACW joint locations by each of the seven readers
showed a median Cohen’s  value of 0.06 (slight agree-
ment; range = 0.00 to 0.20). The association between
ACW pain indicated on a manikin form (patient
Table 2 Clinical anterior chest wall inflammation by patient and physician assessment and concordance between the
two assessmentsa
Assessments SpA group AS group nrSpA group
Patient assessment, N 73 58 15
ACW pain present, n (%) 19 (26.0%) 16 (27.6%) 3 (20.0%)
Physician assessment, N 122 95 27
ACW tenderness present, n (%) 32 (26.2%) 25 (26.3%) 7 (25.9%)
Patient versus physician assessmentb (SpA group) ACW tenderness present ACW tenderness absent Total
ACW pain present, n (%) 12 (16.4%) 7 (9.6%) 19 (26.0%)
ACW pain absent, n (%) 7 (9.6%) 47 (64.4%) 54 (74.0%)
Total, n (%) 19 (26.0%) 54 (74.0%) 73 (100%)
aACW = anterior chest wall; AS = ankylosing spondylitis; nrSpA = nonradiographic spondyloarthritis; SpA = spondyloarthritis. bEstimated Cohen’s  = 0.50 (95% CI
= 0.24 to 0.71).
Table 3 Frequency of MRI-detected lesions recorded concordantly by the majority of readers (at least four of seven)
for each joint and per subjecta
Variables SpA group
(N = 122)
AS group
(N = 95)
nrSpA group
(N = 27)
Control group
(N = 75)
SClJ bone marrow edema 29 (23.8%) 26 (27.4%) 3 (11.1%) 1 (1.3%)
SClJ erosion 14 (11.5%) 13 (13.7%) 1 (3.7%) 2 (2.7%)
SClJ fat infiltration 13 (10.7%) 13 (13.7%) 0 (0%) 1 (1.3%)
SClJ synovitis 16 (13.1%) 13 (13.7%) 3 (11.1%) 1 (1.3%)
MSJ bone marrow edema 41 (33.6%) 35 (36.8%) 6 (22.2%) 6 (8.0%)
MSJ erosion 37 (30.3%) 31 (32.6%) 6 (22.2%) 7 (9.3%)
MSJ fat infiltration 25 (20.5%) 24 (25.3%) 1 (3.7%) 3 (4.0%)
MSJ fusion 14 (11.5%) 14 (14.7%) 0 (0%) 0 (0%)
SCoJ bone marrow edema 8 (6.6%) 8 (8.4%) 0 (0%) 0 (0%)
SCoJ erosion 0 (0%) 0 (0%) 0 (0%) 0 (0%)
SCoJ fat infiltration 4 (3.3%) 4 (4.2%) 0 (0%) 0 (0%)
ACW bone marrow edema (≥1 joint) 54 (44.3%) 47 (49.5%) 7 (25.9%) 7 (9.3%)
ACW erosion (≥1 joint) 42 (34.4%) 35 (36.8%) 7 (25.9%) 9 (12.0%)
ACW fat infiltration (≥1 joint) 33 (27.0%) 32 (33.7%) 1 (3.7%) 4 (5.3%)
ACW ≥1 of 5 lesionsb (≥1 joint) 72 (59.0%) 62 (65.3%) 10 (37.0%) 15 (20.0%)
aACW = anterior chest wall; AS = ankylosing spondylitis; MSJ = manubriosternal joint; nrSpA = nonradiographic axial spondyloarthritis; SClJ = sternoclavicular
joint; SCoJ = sternocostal joint; SpA = spondyloarthritis. bBone marrow edema ACW and/or erosion ACW, fat infiltration ACW, synovitis SClJ, fusion MSJ. The
number of patients with MRI-detected lesions in the entire ACW may be lower than the addition of patients with MRI changes of the three joints SClJ, MSJ and
SCoJ, because some patients showed inflammation in more than one joint. Values are the number of subjects (percentage).
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assessment) and BME in at least one of eight ACW
joint locations was fair for the SpA (median  = 0.21,
range = 0.06 to 0.29) and the nrSpA group (median 
= 0.33, range = 0.17 to 0.44). There was no association
between ACW tenderness and/or ACW pain and
either fat infiltration or erosion in at least one of eight
ACW joint locations (median  for fat infiltration =
0.04, range = -0.04 to 0.15;  = 0.10, range = -0.14 to
0.19) and for erosion (median  = -0.03, range = -0.11
to 0.01;  = -0.09, range = -0.18 to 0.17), respectively,
in SpA patients.
Discussion
In this cross-sectional study, tenderness or spontaneous
pain of the ACW was present in 26% of 122 consecutive
SpA patients at a tertiary outpatient clinic. Symptomatic
patients with long-standing AS and with recent-onset
nrSpA were equally affected, indicating that ACW
inflammation may start early in the disease course.
Compared with these clinical manifestations, involve-
ment by WB MRI was observed more frequently, with
44.3%, 34.4% and 27.0% of patients having BME, erosion
and/or fat infiltration, respectively, in at least one loca-
tion in the ACW. All lesions found by MRI were more
common in AS than in nrSpA patients with BME occur-
ring about twice as frequently in the AS group. There
was no association between clinical and imaging findings
indicative of ACW inflammation.
BME was observed in 9.3%, erosion in 12.0% and fat
infiltration in 5.3% of age- and sex-matched healthy
controls. This may be due to normal variants or age-
related changes. A postmortem microradiographic and
histological study of 31 sternal bones showed indenta-
tions of the MSJ surfaces in 14 of 20 elderly subjects
not affected by rheumatic conditions, as well as hernia-
tions of articular cartilage into bone [28]. Both features
may mimic erosions of the MSJ on MRI. The poor
reproducibility of SClJ erosions may be attributable to
often poorly defined cortical margins of normal SClJ
seen on MRI studies, due to curved joint surfaces, as
well as to the slice thickness used [29]. Another factor
mimicking structural SClJ lesions in the usually young
SpA population is the multistage ossification of the
medial clavicular epiphyseal cartilage between ages 15
and 24, which is used for forensic age diagnostics [30].
In our study, the MSJ was the most frequently affected
joint by active and structural lesions detected by MRI
and may therefore be regarded as the “index joint” of
ACW inflammation. Inflammatory involvement of the
MSJ by various imaging modalities has been reported in
39% to 85% of AS patients [4-6]. This wide range may
be attributable to different disease duration and severity
[31]. In a 10-year retrospective study, radiographic
lesions of the MSJ were observed in 51% and of the SClJ
in 17% of 76 AS patients [4,5]. The frequencies of BME
in 49.5% and of erosion in 36.8% of 95 AS patients in
Table 4 Agreement between clinical assessments and MRI-detected lesions of the anterior chest wall indicative of
inflammationa
Clinical assessmentb MRI-detected lesionc Patient group  value [range]d
ACW tenderness BME SpA 0.06 [0.00 to 0.20]
AS 0.14 [0.06 to 0.20]
nrSpA -0.10 [-0.31 to 0.29]
Erosion SpA -0.03 [-0.11 to 0.01]
AS -0.03 [-0.11 to 0.03]
nrSpA -0.06 [-0.18 to 0.19]
Fat infiltration SpA 0.04 [-0.04 to 0.15]
AS 0.09 [-0.04 to 0.18]
nrSpA -0.20 [-0.23 to 0.15]
ACW pain BME SpA 0.21 [0.06 to 0.29]
AS 0.18 [0.03 to 0.28]
nrSpA 0.33 [0.17 to 0.44]
Erosion SpA -0.09 [-0.18 to 0.17]
AS -0.12 [-0.25 to 0.17]
nrSpA 0.17 [-0.11 to 0.29]
Fat infiltration SpA 0.10 [-0.14 to 0.19]
AS 0.06 [-0.22 to 0.19]
nrSpA 0.17 [0.07 to 0.44]
aACW = anterior chest wall; AS = ankylosing spondylitis; BME = bone marrow edema; MASES = Maastricht Ankylosing Spondylitis Enthesitis Score [16]; nrSpA =
nonradiographic spondyloarthritis; SpA = spondyloarthritis. bACW tenderness in at least one of four MASES points (physician assessment); ACW pain indicated by
patients on a manikin form (patient assessment). cMRI-detected lesion recorded in at least one of eight ACW joint locations by each of the seven readers.
dMedian Cohen’s  values [range] of all seven individual readers.
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our study are comparable to the detection of active
lesions by radionuclide bone scan in 50% and of struc-
tural lesions on coronal tomography in 48% of 50 AS
patients [6]. The combined imaging modalities in this
report also showed a similar distribution of inflamma-
tory lesions among the three ACW joints (SClJ, MSJ
and SCoJ involvement in 20%, 32% and 4%, respectively)
as in our own study.
We found only moderate association between patient
self-report of ACW pain and ACW tenderness upon
pressure, with a frequency of ACW involvement of 26%
for both evaluations. A combined assessment of patient
self-reports and physical examinations containing ten-
derness and swelling of the ACW reported inflammatory
ACW involvement in 58% of 50 AS patients [6].
In our study, we found no agreement between clinical
and imaging findings indicative of inflammation, except
for a fair association of patient self-report of ACW pain
and BME of the ACW. This is in line with a moderate
agreement of 36% to 50% between a composite clinical
evaluation and a combination of scintigraphic and
tomographic findings in 50 AS patients [6]; this study
also reported a better association of imaging lesions
with spontaneous pain reports than with ACW tender-
ness. A possible explanation for the discrepancy between
clinical and WB MRI findings is subclinical ACW
inflammation in SpA patients. This hypothesis is sup-
ported by the observation of an increased radioisotope
uptake in the SClJ and MSJ in 54% of 50 patients with
psoriatic arthritis as opposed to a clinical SClJ involve-
ment in 13% [2]. Subclinical involvement has also been
reported at peripheral entheses in SpA [32]. In 34 SpA
patients, peripheral enthesitis was detected by clinical
examination in 14.4% of the entheses in 62% of the
patients compared with 36% of the entheses in 94% of
the patients by ultrasonography. A tender point upon
clinical examination may not always be indicative of
inflamed enthesis and inflammation detected by imaging
methods such as ultrasonography and MRI may be clini-
cally silent [33].
Given a paucity of histological data regarding sympto-
matic enthesitis, imaging may be regarded as the current
gold standard for diagnosing this inflammatory condi-
tion; however, positive imaging findings may not corre-
late with clinical enthesitis [34]. Our data were unable
to verify the construct validity of the ACW tender
points of the MASES [16], which is the only enthesitis
score to include this area of the body [17], because no
association was observed between clinical and imaging
features of inflammation in our study.
The nonspecific characteristic of chest wall pain may
also partially account for the poor agreement between
clinical and imaging assessment. In a prospective obser-
vational cohort study comprising 58 primary care
practices in Switzerland, a nonspecific painful chest wall
syndrome was found in 1.2% of 24,620 consultations,
which recurred in 57% of the patients within 12 months
[35]. Some of our SpA patients may have indicated non-
specific chest wall pain unrelated to SpA disease activity,
and therefore this may not have been relevant to the
inflammation detected by MRI.
A comparison between two different clinical evalua-
tion methods and an imaging assessment has inherent
limitations. The patient assessment often shows referred
pain distant to sternal inflammation [18-20], whereas
the MASES ACW score focuses on two sternal loca-
tions. Moreover, the first SCoJ is completely covered by
the medial end of the clavicle. The upper location of the
MASES ACW score may therefore reflect tenderness of
the SClJ or the second SCoJ, which articulates with the
MSJ. Although MRI is a sensitive tool for detection of
inflammation of the ACW, it may not be surprising that
it fails to reveal abnormalities in patients who have non-
specific ACW tenderness on sternal palpation. The
assumptions regarding the number of MRI readers and
lesions found on MRI studies also affect the comparison
with clinical assessment methods.
Conclusions
Clinical and WB MRI signs of ACW inflammation were
found in 26% and in up to 44% of SpA patients, respec-
tively, but there was no association between clinical and
imaging findings indicative of inflammation. Conse-
quently, though it is possible that WB MRI may contri-
bute to diagnostic utility, it does not appear to be useful
in explaining the cause of a patient’s symptoms. This
study also raises questions regarding the contribution to
the validity of including ACW tender points in an
enthesitis score.
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